Perinatal psychiatry: Risk factors, treatment data, and specific challenges for clinical researchers

Journal of Clinical Psychiatry

Volumn 69, Issue 4, 2008, Pages 633-634

  Freeman, Marlene P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OLANZAPINE; PAROXETINE; PLACEBO; PSYCHOTROPIC AGENT;

BIPOLAR DISORDER; BREAST FEEDING EDUCATION; CLINICAL PRACTICE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; INFANTICIDE; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL HEALTH CARE; PERINATAL CARE; PREGNANCY DISORDER; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RISK FACTOR; SCHIZOPHRENIA; SHORT SURVEY; SUICIDE;

EID: 44849133670     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0416     Document Type: Short Survey

References (7)

1. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006 Feb;295(5):499-507
2. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal Depression: Prevalence, Screening Accuracy, and Screening Outcomes. Evidence Report/ Technology Assessment No. 119. (Prepared by the RTI-University of North Carolina Evidence-based Practice Center, under Contract No. 290-02-0016.) AHRQ Publication No. 05-E006-2. Rockville, Md: Agency for Healthcare Research and Quality; 2005
3. Dietz PM, Williams SB, Callaghan WM, et al. Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 2007 Oct;164(10):1515-1520
4. Rees AM, Austin MP, Parker GB. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 2008 Mar;42(3):199-205
5. Freeman MP, Davis MF, Sinha P, et al. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord 2008 Jan 16 [Epub ahead of print]
6. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008 Feb;5(2):e45
7. Viguera AC, Nonacs R, Cohen LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000 Feb;157(2):179-184